Non-genetic mechanisms of diabetic nephropathy

被引:0
作者
Qiuxia Han
Hanyu Zhu
Xiangmei Chen
Zhangsuo Liu
机构
[1] Beijing Key Laboratory of Kidney Diseases,Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases
[2] The First Affiliated Hospital of Zhengzhou University,Department of Nephrology
来源
Frontiers of Medicine | 2017年 / 11卷
关键词
diabetic nephropathy; immune inflammatory response; epithelial–mesenchymal transition; apoptosis; mitochondrial damage; epigenetics; podocyte–endothelial communication;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetic nephropathy (DN) is one of the most common microvascular complications in diabetes mellitus patients and is characterized by thickened glomerular basement membrane, increased extracellular matrix formation, and podocyte loss. These phenomena lead to proteinuria and altered glomerular filtration rate, that is, the rate initially increases but progressively decreases. DN has become the leading cause of end-stage renal disease. Its prevalence shows a rapid growth trend and causes heavy social and economic burden in many countries. However, this disease is multifactorial, and its mechanism is poorly understood due to the complex pathogenesis of DN. In this review, we highlight the new molecular insights about the pathogenesis of DN from the aspects of immune inflammation response, epithelial–mesenchymal transition, apoptosis and mitochondrial damage, epigenetics, and podocyte–endothelial communication. This work offers groundwork for understanding the initiation and progression of DN, as well as provides ideas for developing new prevention and treatment measures.
引用
收藏
页码:319 / 332
页数:13
相关论文
共 798 条
  • [31] Bruijn JA(2016)Down-regulation of p38 MAPK and collagen by 1, 25-(OH)2-VD3 in rat models of diabetic nephropathy Chin J Cellular Mol Immunol (Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi) 32 931-80
  • [32] Zhang L(2014)Vitamin D receptor and its protective role in diabetic nephropathy Chin Med J (Engl) 127 365-1549
  • [33] Long J(2015)Anti-inflammatory effects of 1, 25-dihydroxyvitamin D3 in monocytes cultured in serum from patients with type 2 diabetes mellitus and diabetic nephropathy with uremia via Toll-like receptor 4 and nuclear factor-kB p65 Mol Med Rep 12 8215-2207
  • [34] Jiang W(2010)Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily Nat Rev Endocrinol 6 94-232
  • [35] Shi Y(2004)The role of complement activation in atherosclerosis Immunol Res 30 73-e20
  • [36] He X(2007)Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice Diabetologia 50 1541-238
  • [37] Zhou Z(2016)Increased autoreactivity of the complement-activating molecule mannan-binding lectin in a type 1 diabetes model J Diabetes Res 2016 1825738-260
  • [38] Li Y(2014)Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study Diabetologia 57 2201-2661
  • [39] Yeung RO(2015)Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control Clin Exp Immunol 180 227-5455
  • [40] Wang J(2011)Inflammatory gene expression in OVE26 diabetic kidney during the development of nephropathy Nephron, Exp Nephrol 119 e8-45